Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for TCR reprogramming using fusion proteins

Compositions and methods for TCR reprogramming using fusion proteins

US Patent 11085021 · Granted Aug 10, 2021

Estimated economic value: $7,337,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Constrained conditionally activated binding proteins2025
Antibody constructs for CDH19 and CD32025
Antibody constructs for CDH19 and CD32025
Anti-CD19 antibodies and multi-specific binding proteins2025
Binding moiety for conditional activation of immunoglobulin molecules2025
Binding moiety for conditional activation of immunoglobulin molecules2025
Binding moiety for conditional activation of immunoglobulin molecules2025
Multi-specific binding proteins and methods of use thereof2025
Trispecific proteins and methods of use2025
Trispecific proteins and methods of use2025
Trispecific proteins and methods of use2025
Activatable interleukin 12 polypeptides and methods of use thereof2025